Showing results (1-10 of 159) with videos related to
Sort By:
Pageof 16
Research Communications in Chemical Pathology and Pharmacology|June 1, 1981
Reversible metabolism and pharmacokinetics: application to prednisone-prednisoloneJ G Wagner, A R DiSanto, W R Gillespie, et al.Journal of Clinical Pharmacology|July 1, 1980
Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tabletsA R DiSanto, K Y Tserng, D J Chodos, et al.Journal of Pharmaceutical Sciences|January 1, 1975
Bioavailability and pharmacokinetics of prednisone in humansA R Disanto, K A DesanteAntimicrobial Agents and Chemotherapy|August 1, 1981
Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearateA R DiSanto, D J ChodosJournal of Pharmaceutical Sciences|November 1, 1978
Influence of kaolin--pectin suspension on digoxin bioavailabilityK S Albert, J W Ayres, A R DiSanto, et al.Research Communications in Chemical Pathology and Pharmacology|August 1, 1976
Intersubject variation of warfarin binding to protein in serum of normal subjectsA Yacobi, R G Stoll, A R DiSanto, et al.Journal of Pharmaceutical Sciences|December 1, 1977
Generic propoxyphene: need for clinical bioavailability evaluationK A DeSante, R G Stoll, D G Kaiser, et al.JAMA|June 30, 1975
Antibiotic batch certification and bioequivalenceK A DeSante, A R DiSanto, D J Chodos, et al.Journal of Pharmaceutical Sciences|May 1, 1979
Decreased tetracycline bioavailability caused by a bismuth subsalicylate antidiarrheal mixtureK S Albert, R D Welch, K A DeSante, et al.Journal of Pharmaceutical Sciences|September 1, 1982
Relative bioavailability of commercially available ibuprofen oral dosage forms in humansW R Gillespie, A R DiSanto, R E Monovich, et al.Pageof 16